Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy

Stuart Prince, Miro Viitala, Riikka Sjöroos, Ábris Á. Bendes, Jenna H. Rannikko, Daniel A. Patten, Ilaria di Benedetto, Rita Turpin, Arno Ylitalo, Laura Tyni, Carlos R. Figueiredo, Pia Boström, Ilkka Koskivuo, Tiina A. Salminen, Shishir Shetty, Maija Hollmén

Theranostics (2025)

Published on February 17, 2026

DOI: https://doi.org/10.7150/thno.110544

← Back to Publications
I. Tamanna et al. • Aug 10, 2026 • Journal of Proteome Research
Abstract Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites,...
J. Grist et al. • May 4, 2026 • Journal of Neuroinflammation
Abstract Given the prevalence of metabolic perturbations in a variety of neurological and neurodegenerative diseases, understanding and monitoring brain metabolism...
M. Gluud et al. • Mar 8, 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...